CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

Ruo Yu Chen, Chia Jui Yen, Yao Wen Liu, Chun Guo Guo, Chieh Yu Weng, Chien Hsien Lai, Yu Ming Wang, Yih Jyh Lin, Liang Yi Hung

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Centrosomal P4.1-associated protein (CPAP) is overexpressed in hepatocellular carcinoma (HCC) and positively correlated with recurrence and vascular invasion. Here, we found that CPAP plays an important role in HCC malignancies. Functional characterization indicated that CPAP overexpression increases tumor growth, angiogenesis, and metastasis ex vivo and in vivo. In addition, overexpressed CPAP contributes to sorafenib resistance. Mechanical investigation showed that the expression level of CPAP is positively correlated with activated STAT3 in HCC. CPAP acts as a transcriptional coactivator of STAT3 by directly binding with STAT3. Interrupting the interaction between CPAP and STAT3 attenuates STAT3-mediated tumor growth and angiogenesis. Overexpression of CPAP upregulates several STAT3 target genes such as IL-8 and CD44 that are involved in angiogenesis, and CPAP mRNA expression is positively correlated with the levels of both mRNAs in HCC. Knocked-down expression of CPAP impairs IL-6-mediated STAT3 activation, target gene expression, cell migration, and invasion abilities. IL-6/STAT3-mediated angiogenesis is significantly increased by CPAP overexpression and can be blocked by decreased expression of IL-8. Our findings not only shed light on the importance of CPAP in HCC malignancies, but also provide potential therapeutic strategies for inhibiting the angiogenesis pathway and treating metastatic HCC.

Original languageEnglish
JournalCell Death and Differentiation
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Neoplasm Metastasis
Hepatocellular Carcinoma
Proteins
Interleukin-8
Interleukin-6
Neoplasms
STAT3 Transcription Factor
Messenger RNA
Growth
Cell Movement
Blood Vessels
Up-Regulation
Gene Expression
Recurrence
Genes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

Chen, Ruo Yu ; Yen, Chia Jui ; Liu, Yao Wen ; Guo, Chun Guo ; Weng, Chieh Yu ; Lai, Chien Hsien ; Wang, Yu Ming ; Lin, Yih Jyh ; Hung, Liang Yi. / CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity. In: Cell Death and Differentiation. 2019.
@article{bd022ce51c8c424d96c631cd27f6d92b,
title = "CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity",
abstract = "Centrosomal P4.1-associated protein (CPAP) is overexpressed in hepatocellular carcinoma (HCC) and positively correlated with recurrence and vascular invasion. Here, we found that CPAP plays an important role in HCC malignancies. Functional characterization indicated that CPAP overexpression increases tumor growth, angiogenesis, and metastasis ex vivo and in vivo. In addition, overexpressed CPAP contributes to sorafenib resistance. Mechanical investigation showed that the expression level of CPAP is positively correlated with activated STAT3 in HCC. CPAP acts as a transcriptional coactivator of STAT3 by directly binding with STAT3. Interrupting the interaction between CPAP and STAT3 attenuates STAT3-mediated tumor growth and angiogenesis. Overexpression of CPAP upregulates several STAT3 target genes such as IL-8 and CD44 that are involved in angiogenesis, and CPAP mRNA expression is positively correlated with the levels of both mRNAs in HCC. Knocked-down expression of CPAP impairs IL-6-mediated STAT3 activation, target gene expression, cell migration, and invasion abilities. IL-6/STAT3-mediated angiogenesis is significantly increased by CPAP overexpression and can be blocked by decreased expression of IL-8. Our findings not only shed light on the importance of CPAP in HCC malignancies, but also provide potential therapeutic strategies for inhibiting the angiogenesis pathway and treating metastatic HCC.",
author = "Chen, {Ruo Yu} and Yen, {Chia Jui} and Liu, {Yao Wen} and Guo, {Chun Guo} and Weng, {Chieh Yu} and Lai, {Chien Hsien} and Wang, {Yu Ming} and Lin, {Yih Jyh} and Hung, {Liang Yi}",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41418-019-0413-7",
language = "English",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",

}

CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity. / Chen, Ruo Yu; Yen, Chia Jui; Liu, Yao Wen; Guo, Chun Guo; Weng, Chieh Yu; Lai, Chien Hsien; Wang, Yu Ming; Lin, Yih Jyh; Hung, Liang Yi.

In: Cell Death and Differentiation, 01.01.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

AU - Chen, Ruo Yu

AU - Yen, Chia Jui

AU - Liu, Yao Wen

AU - Guo, Chun Guo

AU - Weng, Chieh Yu

AU - Lai, Chien Hsien

AU - Wang, Yu Ming

AU - Lin, Yih Jyh

AU - Hung, Liang Yi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Centrosomal P4.1-associated protein (CPAP) is overexpressed in hepatocellular carcinoma (HCC) and positively correlated with recurrence and vascular invasion. Here, we found that CPAP plays an important role in HCC malignancies. Functional characterization indicated that CPAP overexpression increases tumor growth, angiogenesis, and metastasis ex vivo and in vivo. In addition, overexpressed CPAP contributes to sorafenib resistance. Mechanical investigation showed that the expression level of CPAP is positively correlated with activated STAT3 in HCC. CPAP acts as a transcriptional coactivator of STAT3 by directly binding with STAT3. Interrupting the interaction between CPAP and STAT3 attenuates STAT3-mediated tumor growth and angiogenesis. Overexpression of CPAP upregulates several STAT3 target genes such as IL-8 and CD44 that are involved in angiogenesis, and CPAP mRNA expression is positively correlated with the levels of both mRNAs in HCC. Knocked-down expression of CPAP impairs IL-6-mediated STAT3 activation, target gene expression, cell migration, and invasion abilities. IL-6/STAT3-mediated angiogenesis is significantly increased by CPAP overexpression and can be blocked by decreased expression of IL-8. Our findings not only shed light on the importance of CPAP in HCC malignancies, but also provide potential therapeutic strategies for inhibiting the angiogenesis pathway and treating metastatic HCC.

AB - Centrosomal P4.1-associated protein (CPAP) is overexpressed in hepatocellular carcinoma (HCC) and positively correlated with recurrence and vascular invasion. Here, we found that CPAP plays an important role in HCC malignancies. Functional characterization indicated that CPAP overexpression increases tumor growth, angiogenesis, and metastasis ex vivo and in vivo. In addition, overexpressed CPAP contributes to sorafenib resistance. Mechanical investigation showed that the expression level of CPAP is positively correlated with activated STAT3 in HCC. CPAP acts as a transcriptional coactivator of STAT3 by directly binding with STAT3. Interrupting the interaction between CPAP and STAT3 attenuates STAT3-mediated tumor growth and angiogenesis. Overexpression of CPAP upregulates several STAT3 target genes such as IL-8 and CD44 that are involved in angiogenesis, and CPAP mRNA expression is positively correlated with the levels of both mRNAs in HCC. Knocked-down expression of CPAP impairs IL-6-mediated STAT3 activation, target gene expression, cell migration, and invasion abilities. IL-6/STAT3-mediated angiogenesis is significantly increased by CPAP overexpression and can be blocked by decreased expression of IL-8. Our findings not only shed light on the importance of CPAP in HCC malignancies, but also provide potential therapeutic strategies for inhibiting the angiogenesis pathway and treating metastatic HCC.

UR - http://www.scopus.com/inward/record.url?scp=85072958551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072958551&partnerID=8YFLogxK

U2 - 10.1038/s41418-019-0413-7

DO - 10.1038/s41418-019-0413-7

M3 - Article

C2 - 31511651

AN - SCOPUS:85072958551

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

ER -